MedTrace Logo

Thyroxin in Subclinical Hypothyroidism

NCT03712683 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 168

Last updated 2018-10-29

No results posted yet for this study

Summary

Subclinical hypothyroidism(SCH) is the elevated thyroid stimulating hormone (TSH) with normal free Thyroxine levels and it is a mild or compensated form of primary hypothyroidism. It has been suggested that SCH is more prevalent in infertile women (especially in women with ovulatory disorders.Various rates of SCH was reported in infertile women in different populations

Conditions

  • Sub Clinical Hypothyroidism
  • Pregnancy Loss

Interventions

DRUG

Thyroxine

Thyroxine was prescribed with the diagnosis of SCH and continued when pregnancy was confirmed

Sponsors & Collaborators

  • Hawler Medical University

    lead OTHER

Principal Investigators

  • Ariana Kh. Jawad, CABOG · Hawler Medical University

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
42 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-01
Primary Completion
2017-07-01
Completion
2017-07-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03712683 on ClinicalTrials.gov